xTAG®

xTAG Respiratory Viral Panel: Comprehensive. Reliable. Fast.

Advantages and Benefits

Advantages of xTAG RVP:

  • Sensitive. Excellent sensitivity, including 96.4% for influenza A and 100% for RSV A and B subtypes1
  • Comprehensive. A multiplexed test that goes beyond flu and RSV. Tests for 12 different viruses and subtypes, representing almost all major respiratory viruses encountered in clinical practice and public health surveillance
  • Fast. Provides same-day or next-day results
  • Cost-Effective. One price for information on all viral targets
     

xTAG RVP Clinical Performance:


Benefits of xTAG RVP:

  • Eliminates guesswork - detects 85% of the viral causes of colds and flu3
  • Can be used to rule out novel H1N1 influenza A (swine flu)2
  • Helps you make the most of your therapeutic window – same-day or next-day results.
  • Provides comfort to patients.
  • Assists in improving patient management.
  • Saves patients and healthcare facilities money through avoidance of the inappropriate use of antibiotics.

 

Case Studies

Atypical flu symptoms
A fifteen-year-old male presented to the ER with the chief complaint of altered mental status with flat affect, confusion and disorganized speech and behavior. Read case study

 
A one-year-old with congenital hydrocephalus presented to the ER with high fever. Read case study
 
 
High fever in an infant
A three-week-old baby was brought to the ER by his mother, who said he felt warm and was irritable. Read case study
 
 
A two-year-old girl presented with a two-day history of high fever (105°F) and rapid breathing. Read case study
 
 
Outbreak in the NICU
Recently, the hospital’s neonatal intensive care unit (NICU) experienced an outbreak of a respiratory virus that affected about one-third of all babies in the unit. Read case study
 
 
Mysterious respiratory failure
A one-year-old boy had been in the intensive care unit for several weeks with respiratory failure and no other significant symptoms. Read case study

 

 References:

  1. xTAG RVP Package Insert. Luminex Molecular Diagnostics, Inc.
  2. Ginocchio et al., JCM 2009 (e-pub ahead of print).
    Free fulltext version
  3. J. Mahony, et al. Establishing the Epidemiology of Respiratory Virus Infections Using Molecular Technology, Poster presented at the 107th ASM Meeting

For full indications for use, limitations, warnings and precautions, see package insert.

Site Information

Jump to main navigation links

Access Keys Legend

0
Access Keys legend.
1
Return to the "Home Page"
N
Go to the main navigation links
S
Skip past the main navigation links to the main content of the page.